Sudden Cardiac Arrest in a Patient With Myxedema Coma and COVID-19

Neal M. Dixit; Katie P. Truong; Soniya V. Rabadia; David Li; Pratyaksh K. Srivastava; Tina Mosaferi; Marcella A. Calfon Press; Ines Donangelo; Theodoros Kelesidis


J Endo Soc. 2020;4(10) 

In This Article


We report, to our knowledge, the first case of MC with SARS-CoV-2 infection complicated by sudden cardiac arrest. We discuss how SARS-CoV-2 may have precipitated multiorgan damage and SCA in our patient (Figure 1). Further studies are needed to elucidate the direct effects of SARS-CoV-2 infection on heart and thyroid tissues. We suggest prompt treatment of MC with conservative doses of IV levothyroxine for patients with preexisting cardiovascular disease or in acute illnesses known to cause cardiac damage such as COVID-19.